Payer-Negotiated Prices in the Diagnosis and Management of Thyroid Cancer in 2021
Roy Xiao, Vinay K. Rathi, Cary P. Gross, Joseph S. Ross, Rosh K.V. Sethi
Abstract
This study examines price availability and variation for thyroid cancer care at National Cancer Institute (NCI)–Designated Cancer Centers following a 2021 CMS policy reform requiring hospitals to disclose commercial payer-specific negotiated prices for all items and services.
Topics & Concepts
MedicineThyroid cancerCancerFamily medicineActuarial scienceInternal medicineBusinessRadiation Dose and ImagingPharmaceutical industry and healthcareRadiology practices and education